Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Insider Trading Scheme Concludes With Guilty Plea

This article was originally published in The Pink Sheet Daily

Executive Summary

The first-ever prosecution of an agency employee will likely result in jail time for the chemist. For the agency, the result is a new electronic monitoring system.
Advertisement

Related Content

FDA's Confidential Information Protections Draw Questions From Congress
Insider Trading: Pharma Employees Increasingly In SEC Crosshairs
FDA Seeks New Chief Information Officer In Privacy And Security Overhaul
FDA Seeks New Chief Information Officer As Privacy And Security Policies Get Overhaul
Law & Order: FDA? Another FDA Employee Accused In A High-Profile Case
Learning To Share: FDA Taps J&J Veteran As New Chief Information Officer
No Comparison: Viibryd’s Path Of Least Resistance Through FDA Could Mean Rocky Marketing
FDA Insider Trading Case Spurs FDA To Bolster Data Security
Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades
Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades

Topics

Advertisement
UsernamePublicRestriction

Register

PS072902

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel